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 Diabetes mellitus (DM) is ricing nowadays. DM is a metabolic deasease 
characterized by increasing of glucose blood level for prolonged time. Patient 
with DM must take medicine for lowering glucose levels in whole life. 
Synthetic anti-diabetic agent is commonly used and significantly able to 
maintain the glucose blood levels. However, many side effects will occur 
during the treatment. Further, people are trying to find an alternative 
medicine for DM treatment. This paper will discuss about an alternative 
medicine for anti-diabetic agent that is called Andrographis paniculata 
(Burm. f.) Nees based in-vivo study. Search data obtained from PubMed, 
PMC (PubMed Central), International Food and Research Journal, and 
Google search engine. Inclution and exclution criteria were used for selection 
of journals. Inclution criteria were taken is in-vivo study of Andrographis 
paniculata as anti-diabetic, published in 2000-2014, and free full text journal 
or PubReader (full text journal in PubMed Central) in English or Indonesian 
language. Base on reviewed journals that was conducted, anti-diabetic agent 
of Andrographis paniculata was found in extract, in fractional coumpund 
(i.e. andrographolide or its analogue AL-1: andrographolide-lipoic acid), and 
in combination with synthetic drug or other herbal. Therefore, Andrographis 
paniculata is potentially developed as an alternative anti-diabetic agent.
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1. INTRODUCTION 
Diabetes mellitus (DM) is a metabolic disease in which there are high blood glucose levels over a 
long period. DM is characterized by hyperglycemic regarding to the damage of metabolism process of 
carbohydrates, proteins or fats that is causing the impaired insulin secretion, insulin activity or a combination 
of both. Diabetes is classified into two main types, that are diabetes type 1 or IDDM (insulin-dependent 
diabetes mellitus) and type 2 or NIDDM (non-insulin-dependent diabetes mellitus) [1]. Type 1 of DM occur 
due to the destruction of the beta cells and usually followed by insulin deficiency (absolute insulin 
deficiency) or in the other word that the body can not produce insulin. Whereas, type 2 of DM is a condition 
when the body still able to produces insulin however there is interference on the process of insulin secretion 
due to the background of insulin resistance (relative insulin deficiency). In addition to the above two types of 
DM, there are also diabetes caused by destruction of beta cell function due to genetic factors, deseases of the 
exocrine pancreas (such as cystic fibrosis), and gestational DM [2]. 
International Diabetes Federation (IDF) predicted that people with DM reached 371 million in 2012 
and 552 million in 2030. The average of the increasing case is 3 people every second [3],[4]. Therefore, it is 
necessary to find the integrated treatment of DM by using an alternative medicine such as herbal medicine or 
using a combination between the synthetic drugs and herbal medicine. This paper will discuss intensively 
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about the anti-diabetic activity of Andrographis paniculata, a plant species that tradionally used as 
antidiabetic agent, based on in-vivo study. 
 
 
2. RESEARCH METHOD 
Evidence Based Medicine (EBM) from PubMed, PMC (PubMed Central), International Food and 
Research Journal, and Google search engine for Indonesian language journal on the topic of to the anti-
diabetic activity of Andrographis paniculata (Burm. f.) Nees were used as the source of this literature review. 
Andrographis panculata, diabetes, anti-diabetic activity of Andrographis paniculata, and combination of 
Andrographis paniculata as anti-diabetic were used as the keywords for searching the journals. Inclution and 
exclution criteria were used for selection of the journals. Inclution criteria were the journals that discuss 
about in-vivo study of Andrographis paniculata as anti-diabetic, journals published in 2000-2014, and free 
full text journal or PubReader (full text journal in PubMed Central) published in English or Indonesian 
language. Meanwhile the exclution criteria were the journals that no have relation between Andrographis 
paniculata to anti-diabetic activity, journal of other hebal medicine for anti-diabetic and journal not publish 
in 2000 – 2014. 
There were seven jounals have been reviewed, five journals published in English and two journals in 
Indonesian. Each journal then was evaluated on the research objectives, research methods, and parameters 
used as well as the discussion of research results. 
 
 
3. RESULTS AND ANALYSIS 
Recently, the pharmacological and non pharmacological therapies were known as the DM therapy. 
The pharmacological therapy is commonly using some hypoglycemic oral drugs such as sulfonyl urea, glinid, 
thiazolidinediones, binguadit, or its combination of these drugs. Pharmacological therapy is also can be done 
by using insulin injections directly or with DPP-4 inhibitors (insulin sensitizing). While non-pharmacological 
therapies are some activities that can help to maintain normal glucose blood levels  such as changing the 
lifestyle and behavior (i.e. avoiding smoking and alcohol), taking a good diet, and doing a physical exercise 
[5]. 
One alternative therapy for DM is using herbal medicine, which has been chosen by community. 
Treatment with herbal medicine is more easily accepted by community since it is considered to have low side 
effects when properly used (proper dosage, indications, timing, manner of use and accuracy of determination 
material from herbal medicine) [6].  
Numbers of research on medicinal plants that potentially developed as an anti-diabetic agent were 
conducted. Medicinal plants can be used as an alternative treatment for DM is sambiloto (Andrographis 
paniculata) [6]. Besides as anti-diabetic agent, Andrographis paniculata had also been widely studied as 
analgetic, antioxidants [6], anti-malarial [7], antibacterial, and hepatoprotector [8]. 
Andrographis paniculata is containing some phytoconstituent compound such as flavonoids, 
diterpenoids, and polyphenol [9],[10]. The major compounds inside the Andrographis paniculata which is 
has a biological activity is a diterpene lactone group, which consists of andrographolide, neoandrographolide, 
14-deoxyandrographolide, andrograpin, 14-acetylandrographolide, 14-deoxydehidroandrographolide, and 
homoandrographolide. Andrographolide is a diterpene lactone compound that most dominant, approximately 
4% of the whole plant [9]. This andrographolide is an active compound as antidiabetes [11]. 
Various studies related to the pharmacological activity of Andrographis paniculata (especially 
andrographolide as compounds that have pharmacological activity as anti-diabetic agent) had been carried 
out both in-vivo and in vitro study. Some of them had been through clinical trials in humans about safety and 
afficacy. The chemical structure of andrographolide can be seen on Figure 1 [12]. 
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Figure 1. Chemical structure of andrographolide [12] 
 
 
3.1. Physicochemical properties of andrographolide 
Andrographolide is the main compound in Andrographis paniculata, especially on the leaves. The 
IUPAC name of andrographolide is 3α, 14, 15, 18-tetrahydroxy-5β, 9βh, 10α-labda-8, 12-dien-16-oic acid γ-
lactone (Figure 1). The molecular formula of andrographolide is C20H30O5 with molecular weight is 350.4 
gram/mole. Andrographolide is not very soluble in water, soluble in acetone, chloroform, ether and ethanol 
(hot ethanol). Cristalline of andrographolide is highly stable for more than 3 months with the melting point is 
235.3 °C. The purity of andrographolide can be determined by Thin-Layer Chromatography (TLC) [12], 
High Performance Liquid Chromatography (HPLC) [13], or Liquid Chromatography-Mass Spectrometry 
(LCMS) [12]. 
Aryani reported that the andrographolide level of Andrographis paniculata at different areas in 
Indonesia has variation on consentration, starting from 6.25% in Banyuwangi to 14.69% in Surabaya. 
Identification was conducted for 96% ethanolic extract from maceration process [13]. The Andrographis 
paniculata extract that can be used as the anti-diabetic agent is a extract that containing andrographolide not 
less than 15% [14]. 
 
3.2. Mechanism of induction of diabetes in rats 
During the study of anti-diabetic activity of Andrographis paniculata, rat was used as the animal for 
the test. In various studies on anti-diabetic activity of a drug on in-vivo study, most researchers use 
streptozotosin (STZ) [15],[16] or alloxan [17] to induce insulin resistance. Alloxan usually used to induce 
type 1 diabetes (IDDM), but later revealed that alloxan is not selective for rat pancreatic beta cells. While 
STZ can be used to induce both types of diabetes (IDDM and NIDDM) with a toxic effect on the beta sel 
[18],[19]. In few studies [11],[19]-[22] that was included in this review, for induction the insulin resistance 
was using high fructose-fat fed. The insulin resistence occured due to the increase of fatty acid metabolism in 
the cells (intracellular) and resulting fatty acid CoA, diacylglycerol, and caramides. The results of this 
metabolism causing a decrease of the ability of insulin receptors and activate the PI 3-kinase protein that can 
decrease the activity of GLUT-4 as glucose transporter [23]. The composition of the high fructose-fat fed are 
feed (80%), lard (15%), and duck egg yolk (5%) [20] or with a combination of fructose (36%), lard (15%), 
and egg yolks (5%) [11]. 
 
3.3. Toxicity evaluation of Andrographis Paniculata 
To ensure that the Andrographis paniculata and andrographolide as an anti-diabetic agent can be 
used safely, it had been conducted a research on the levels of toxicity in some test subjects with a variety of 
administration route [12]. Detail explanation of toxic effects of Andrographis paniculata and 
andrographolide can be seen in Table 1. 
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Table 1. Dosage and toxicity of Andrographis paniculata and its major natural product andrographolide [12] 
Product name Dosage/duration/route Experimental models Toxic effects 
Andrographolide 10 mg/kg for 3 weeks Human No 
Andrographolide 500 mg/kg bw for 7 days i.p. Mice No 
Andrographolide 25-75 µM Platelets No cytotoxicity 
Andrographis paniculata 20 mg/kg bw for 60 days, oral Rats No 
Andrographolide 22-55 µg/kg, i.v. Mice Lowering mortality 
Andrographis paniculata 1g/kg/day for 4, 6, and 8 weeks Rats No 
Andrographolide 100 mg/kg, i.p. Mice No 
Andrographolide 10 mg/kg, i.v Rats No 
Note: i.p.: intraperitoneal; i.v.: intravenous; and bw: body weight. 
 
 
3.4. Comparison of Andrographis paniculata extract and andrographolide 
Ethanolic extract of Andrographis paniculata in rats that induced by streptozotocin (STZ) had a 
significant effect on blood glucose levels and decreased the activity of the enzyme glucose-6-phosphatase. 
However, after 14 days of administration, the hypoglycemic activity was decline [15]. 
Nugroho et al reported that Andrographis paniculata gave an effect on lowering blood glucose 
levels in type 2 of diabetic rats induced by high fructose-fat fed. This study compared the ability of 
Andrographis paniculata extract and andrographolide as active compound for lowering blood glucose levels 
on various dose [11]. The optimum dosage for ethanolic extract of Andrographis paniculata was 434.6 
mg/kg bw [20]. Male Wistar rats were used for animals test. The rats were divided into five groups that were 
given a high fructose-fat fed for 55 days and 1 normal group (not supplied).  The five groups consists of two 
groups was given a purified extract (at the dose of 434.6 mg/kg bw and 1303.8 mg/kg bw twice daily, oraly), 
two groups of andrographolide (at the dose of 1.5 mg / kg bw and 4.5 mg / kg bw twice daily) and the 
metformin group at the dose of 45 mg / kg bw oraly, twice daily as a standard [11]. 
The result showed that either extract of Andrographis paniculata or their active compound i.e 
andrographolide has an activity to reduce the glucose level and reduce the lipid levels (p<0.05). These results 
were identified by measuring the increase of blood glucose levels preprandial and postprandial after 55 days 
compared to the control group and metformin group. There was no significant difference between 
hypoglycemic effects of Andrographis paniculata extract and synthesis andrographolide on the dose that had 
been tested [11]. 
The mechanism of anti-hyperglycemic andrographolid is not determined well yet. However some of 
the parameters used to determine the activity of Andrographis paniculata as anti-diabetic are as follow: (1) 
preprandial and postprandial blood glucose levels [11],[20] (2) expression of GLUT-4 protein in muscle 
tissues [20],[17] (3) hypoglycemic activity of glibenklamide [20] and (4) HOMA-IR index (homeostatic 
model assessment-insulin resistance) [19]. 
HOMA-IR index is rarely used for indicator of insulin resistance. This index is calculated by 
multiplying fasting glucose and fasting insulin levels then divide by a constant. When the HOMA-IR index is 
low, it means that anti-diabetic activity of the compound/extract higher. Andriawan et al [19] conducted an 
experiment on anti-diabetic activity of Andrographis paniculata induced by high fructose-fat fed using 
HOMA-IR as the parameter. The result was a little different than previous study. The best dose to decrease 
the HOMA-IR index was obtained from purified extract of Andrographis paniculata compared to the 
andrographolide as the active biological constituent [19] at the dose was 1303.8 mg/kg bw. Thus, the pure 
biological active compound (syntetic compound) from a plant is not always better than their extract. This 
may happen because of in this plant containing other compounds that work synergistically to reduce the 
glucose blood level. 
 
3.5. Combination of Andrographis paniculata purified extract with metformin 
Herbal medicine well known about its safety, however numbers of herbal medicine are not widely 
known by the community, especially in extracts dosage form.  The use of herbal medicine alone is not 
enough to overcome metabolic diseases such as DM. Based on that, sometime the communities combine the 
herbal medicines and synthetic drugs. However, problems may occur during the treatment. There is an 
interaction between herbal and synthetic drugs, where herbal medicine can improve the effectiveness of 
synthetic drugs or contrarily [24]. 
Syamsul et al [20] had done a research on the efficacy of the combination of purified   Andrographis 
paniculata and metformin in DM type 2 of rat. The male rats of Sprague-Dawley strain was used for the 
animals test. The diabetic rats were induced by high fructose-fat fed. In this study as much as 36 rats were 
divided into 6 groups: one group of normal rats and 5 groups of diabetic rats. Diabetic rats groups consisting 
of a negative control group, positive control group (diabetic rats were given metformin 45 mg/kg bw), the 
group given purified extract of Andrographis paniculata at the dose of 434.6 mg/kg bw, the group given 
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combination of metformin at the dose of 45 mg/kg bw and purified extract of Andrographis paniculata at the 
dose of 434.6 mg/kg bw (combination 1), and the last group was given a half dose of metformin (22.5 mg/ kg 
bw and purified extract of Andrographis paniculata at the dose of 434.6 mg/kg bw). All groups administered 
orally twice a day. The consentrasion of the andrographolide in the extract that was used not less than 15% 
[14]. The parameter used in the determination of hypoglycemic activity in this study was the expression of 
GLUT-4 protein in muscle tissue. The more of GLUT-4 protein expression occurred the more glucose was 
transported to muscle tissue, so that the blood glucose level will decrease [20]. 
Combination of metformin and purified extract of Andrographis paniculata dropped the metformin 
activity significantly (p<0.05) after 55 days. The decrease of metformin activity was might regarding to the 
drop of metformin absorption. This result was found on the first combination and second combination20. 
Hence, further study on interaction between metformin and purified extract of Andrographis paniculata is 
needed to avoid the interaction between metformin and Andrographis paniculata extract. 
 
3.6. Combination of Andrographis paniculata purified extract with other herbal medicine 
During the optimization of the DM therapy often used a combination of several herbal medicines. 
Nugroho et al [21] had done a research on the effects of combination of n-hexane insoluble fraction of 
ethanolic extract of Andrographis paniculata (HIFA) with other herbal medicines to improve their anti-
diabetic effect. In that study, HIFA combined with curcuminoid fraction of Curcuma xanthorriza (CFC) and 
HIFA combined with ethyl acetate soluble fraction of propolis (ESP). 
Figure 2 is showing the combination of HIFA and CFC provides the best hypoglycemic effect 
compare to HIFA that given singly or in combination with ESP. While at HIFA combination with ESP shows 
a higher decrease in serum glucose levels than HIFA singly, even though the increase is not significantly. 
Thus this combination (HIFA-CFC) was potentially developed as the one of chosen therapy using herbal 
medicine [21]. 
 
 
 
 
Figure 2. Effect of metformin (positive control), single treatment of HIFA, combination HIFA-CFC,and 
combination HIFA-ESF on blood glucose levels (mg/dL) in high-fructose-fat-fed rats (a) and the percentage 
of reduction in blood glucose levels (b) [21] 
 
 
Other herbal that can be combined with Andrographis paniculata is Centella asiatica L. Centella 
asiatica effectively for anti-diabetic in diabetic rats induced by streptozotosin based on measurement of 
serum levels of glucose and their hepatic glycogen levels [16]. Alkaloids, flavonoids, terpenoids, and 
saponins are found in the Centella asiatica which are scattered throughout the plant. Important active 
compound in Centella asiatica is asiaticoside, a triterpen compound [25]. 
Andrographolide-enriched extract of Andrograpis paniculata (AEEAP) combined with asiaticoside-
enriched extract of Centella asiatica (AEECA) gave an anti-diabetic effect on diabetic rats induced by high-
fructose fat fed [22]. 
Andrographolide-enriched extract of Andrographis paniculata (AEEAP) was made by using a 
several times of fractionation of n-hexane, ethyl acetate and ethanol. As well as the preparation of 
asiaticoside-enriched extract of Centella asiatica (AEECA) was similar to the preparation of AEEAP. It was 
estimated that in the two extracts were andrographolide and asiaticoside with high levels of active 
constituent, respectively. 
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This study was done by combining AEEAP and AEECA at 3 dose ratio (i.e. AEEAP: AEECA = 
70:30, 50:50, and 30:70, respectively) compared to the single dose of AEEAP, AEECA, and metformin. The 
entire test group, either single dose or their combination provide results with significantly lower blood sugar 
levels (P < 0.05). The best results were obtained from a combination AEEAP and AEECA at ratio = 70:30 by 
decreasing the blood glucose levels to 68.13%, higher than the single dose of metformin that only 62.63%. In 
addition, except lowering the blood glucose levels, the combination of AEECA and AEEAP was significantly 
decrese the levels of cholesterol, LDL, triglyserides [22]. 
 
3.7. Analogue of andrographolide 
Study on anti-diabetic activity of Andrographis paniculata was not only at the active compound, i.e. 
andrographolide. Reseacher start to study the analogue of andrographolid known as andrographolide lipoic 
acid. This analogue is potentially developed for the alternative agent on diabetes treatment. Andrographolide 
lipoic acid (AL-1) is a result of the conjugation of andrographolide and lipoic cid (LA) [26] which both of 
them have anti-diabetic activity. Lipoic acid itself is a health supplement that used extensively in Germany 
and used in the treatment of symptomatic diabetic neuropathy over 20 years. By looking at the advantages of 
each component (i.e. andrographolide and lipoic acid), Zhang et al [17] had done a research on the efficacy 
and possiblelilty of mechanisms action of the conjugate compound of andrographolide and lipoic acid. 
Research on the efficacy of AL-1 was using animals test. BALB/c female mice were induced using 
alloxan to have diabetic mice. Only rats with blood glucose levels higher than 16.7 mM was used in this 
experiment. Further, the rats were divided into 6 groups: i.e. control group (not given alloxan), the group 
given AL-1 (at doses of 20, 40, and 80 mg/kg bw, respectively), the group given andrographolide (at dose of 
50 mg/kg bw that was equal to molar dose of 80 mg / kg bw AL-1), and the group given gibenklamide at 1.2 
mg/kg bw as the positive control. All groups were given through intragastric route once a day for 6 days. The 
parameters used for anti-diabetic activity of AL-1 was by measuring the fasting blood glucose, serum insulin 
levels, GLUT-4 protein expression, the ability of dysfunction preventive or destruction of beta cells by 
patologic and immunohistochemical analysis of the mouse pancreas [17]. 
Blood glucose levels of diabetic rats that were fed with AL-1 at the dose of 80 mg/kg bw were the 
group that intensively decrease on the blood glucose levels on the day of 0,  which was about 65%. This 
change was 2 times higher compared to the andrographolide group with the dose of 50 mg/kg bw with the 
decline about 32.3%. Thus, giving AL-1 was more effective in lowering blood glucose levels. While the test 
of insulin serum levels, AL-1 at dose 80 mg/kg bw increase the insulin serum levels better than 
andrographolide at the dose   of 50 mg/kg bw. The same results were also shown on pathologic and 
immunohistochemical analysis of mouse pancreatic test. In that study, Zhang et al proved that the AL-1 
could be one of the anti-diabetic agents by lowering fasting glucose levels as well as protection against beta 
cell destruction [17]. 
 
 
 
 
Figure 3. AL-1 elevated GLUT-4 translocation to the plasma membrane of soleus muscles [17] 
 
 
The soleus muscles were isolated and GLUT-4 contents in plasma were analized using western blot. 
Figure 3 explain the AL-1 elevated GLUT-4 translocation to the plasma membrane of soleus muscles. 
GLUT-4 protein levels in diabetic rats only 49.5% compared to non-diabetic rats. Andrographolide treatment 
with the dose of 50 mg/kg bw and AL-1 the dose of 80 mg/kg bw increases the GLUT-4 protein levels up to 
94.6% and 84.7% , respectively. The mechanism of andrographolide and LA for lowering blood glucose 
levels was identified by measuring the increase of GLUT-4 expression of protein in muscle tissue. Hence, 
more glucose was being used in muscle tissue [17],[20],[26]. 
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4. CONCLUSION 
Based on the seven journals that were reviewed, it can be concluded that Andrographis paniculata 
has an anti-diabetic activity. The anti-diabetic activity of Andrographis paniculata was found in the ethanolic 
extract and in the fractional coumpund (i.e. andrographolide or its analogue AL-1: andrographolide-lipoic 
acid). Anti-diabetic activity of Andrographis paniculata was found too in combination with synthetic drug 
(i.e. metformin). However, Andrographis paniculata decreased metformin absorbtion but not significantly. 
Combination of Andrographis paniculata with other herbal medicine (i.e. Centella asiatica, Curcuma 
xanthorriza and propolis) increased Andrographis paniculata activity. Therefore, Andrographis paniculata is 
potentially developed as an alternative anti-diabetic agent. Further study can explore the mechanism of action 
of Andrographis paniculata as anti-diabetic in their extract, fractional compound and combination with 
synthetic drug or other herbal. 
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